|
End-of-day quote
Korea S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 189,600.00 KRW | -2.27% |
|
-3.02% | +9.99% |
| 08-25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| 08-23 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.27% | -3.02% | +6.76% | +0.19% | +9.99% | +14.22% | +51.50% | -18.22% | +145.06% | 32.87B | |
| -1.01% | +1.48% | +5.08% | +19.59% | +9.30% | +1.66% | +23.62% | -23.06% | +213.83% | 51.65B | |
| -0.39% | -1.23% | +12.73% | +36.88% | +166.19% | +468.80% | +557.22% | +673.23% | - | 45.31B | |
| +0.81% | +4.98% | +22.74% | +61.54% | +16.10% | +39.38% | +17.99% | +1.24% | +245.75% | 42.7B | |
| -0.49% | -0.41% | +15.17% | +24.10% | +23.54% | +21.50% | +85.72% | +32.71% | +1,240.93% | 42.79B | |
| +0.90% | +1.64% | +4.90% | +44.08% | +10.08% | +31.74% | +136.29% | +244.06% | +2,178.81% | 17.14B | |
| -1.12% | -3.45% | -1.09% | +4.60% | - | - | - | - | - | 16.61B | |
| -1.70% | +3.06% | +8.82% | +17.53% | +16.70% | +11.11% | +28.57% | -38.66% | +98.34% | 15.01B | |
| -0.22% | +2.49% | +32.51% | +89.64% | +49.00% | +81.55% | +49.54% | -32.09% | +257.62% | 14.21B | |
| +0.33% | -1.80% | +0.36% | +48.78% | -7.04% | -1.38% | -33.65% | -33.05% | +124.98% | 13.03B | |
| +0.58% | +13.09% | +61.43% | +48.46% | +17.31% | -9.21% | - | - | - | 12.4B | |
| +0.05% | -0.16% | +1.04% | +50.85% | +23.05% | +27.43% | -7.53% | -41.31% | +173.90% | 11.34B | |
| +3.48% | -9.25% | +20.48% | +79.99% | +63.28% | +45.88% | +63.80% | -46.57% | - | 11.69B | |
| -1.86% | -2.81% | -11.31% | -8.56% | -16.61% | +48.52% | +466.59% | +246.21% | +2,397.51% | 11.17B | |
| -0.78% | +3.75% | +12.72% | -17.08% | -20.26% | +49.59% | +54.38% | +62.16% | +104.14% | 10.56B | |
| +3.63% | -1.70% | +20.22% | +8.28% | +28.81% | +692.57% | +1,645.47% | +39.68% | - | 10.28B | |
| +0.08% | +0.18% | +0.50% | +62.96% | +78.79% | +256.35% | +478.44% | - | - | 10.17B | |
| -1.63% | -2.17% | +13.18% | +54.20% | +60.07% | +183.91% | +533.52% | +112.72% | - | 10.53B | |
| +0.10% | -2.91% | +10.97% | +50.46% | +72.23% | +163.96% | +642.86% | +219.05% | +1,340.90% | 9.74B | |
| +0.86% | +25.05% | +119.50% | +172.47% | +184.54% | +83.30% | +94.60% | -5.51% | +2,003.57% | 9.78B | |
| Average | -0.03% | +4.64% | +17.83% | +42.45% | +41.32% | +116.36% | +271.61% | +81.92% | +809.64% | 19.95B | |
| Weighted average by Cap. | -0.28% | +3.80% | +15.02% | +36.75% | +42.14% | +110.15% | +207.18% | +108.25% | +659.66% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
